4.6 Article

Mesenchymal Stem Cells Inhibit Breast Cancer Cell Migration and Invasion Through Secretion of Tissue Inhibitor of Metalloproteinase-1 and-2

Journal

MOLECULAR CARCINOGENESIS
Volume 54, Issue 10, Pages 1214-1219

Publisher

WILEY
DOI: 10.1002/mc.22178

Keywords

bone marrow mesenchymal stem cells; metastasis; TIMP-1; TIMP-2

Funding

  1. Dean's Bequest Fund, Otago School of Medical Sciences, University of Otago
  2. University of Otago Research Grant
  3. Department of Pharmacology and Toxicology, University of Otago, New Zealand

Ask authors/readers for more resources

Mesenchymal stem cells (MSCs) form part of tumor stroma, and are typically considered to be pro-tumorigenic, promoting continuing tumor growth and metastasis. Here, we describe a mechanism by which MSCs may be anti-tumorigenic, through inhibition of breast cancer cell migration and invasion, an important part of metastasis. MDA-MB231 and T47D cells were co-cultured in a Transwell insert above MSCs or MSC conditioned media and their migration or invasion through Matrigel measured. The conditioned media was found to inhibit breast cancer cell movement. TIMP-1 and TIMP-2, inhibitors of matrix metalloproteinases (MMPs), were identified as candidates for this inhibition and enhanced secretion of MMPs was not sufficient to counter the anti-migratory effects of TIMP expression. Inhibition of TIMP activity showed that TIMP-1 and TIMP-2 together were largely responsible for the reduction of migration and invasion by MSCs. Therefore, MSCs may play anti-tumorigenic, anti-metastatic roles in tumor development, with the overall outcome dependent upon the balance of pro-and anti-tumorigenic molecules secreted. (C) 2014 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available